OmegAvail™ Marine TG Liquid
(formerly Omega Marine Liquid) is a high potency omega 3 oil, featuring our
TruTG™ fish oil in the form found in nature, and is still presented in a
pleasant tasting, lemon flavored liquid.
OmegAvail™ Marine TG Liquid is a viable option for patients who prefer to
swallow fewer capsules and for those requiring high doses.
The TruTG™ seal, found only with Designs for Health fish oils, ensures:
- Unmatched TG potency - Only fish oil blends and concentrates containing
the TruTG™ seal are 90+% triglyceride (TG) bound omega-3 fish oils.
- As found in nature - EPA and DHA are found naturally in fish in the
triglyceride form.
- Increased bioavailability - Research shows enhanced bioavailability of
triglyceride bound omega fats over ethyl ester forms
Great care has been taken in selection of raw materials, and extensive
purification is utilized to guarantee that our OmegAvail™ Marine TG Liquid is
free of contamination by environmental pollutants. OmegAvail™ Marine TG Liquid
is processed without solvents, and is completely free of chemicals such as
hexane. Third party testing also guarantees that it is free of pesticides, PCBs,
dioxin, and heavy metals including mercury.
This oil may become cloudy when refrigerated, which is normal and does not
alter product efficacy. Natural vitamin E has been added to keep the oil fresh
by preventing oxidative damage.
You must login or register in order to purchase.
Softgels are now available here
Serving Size: 1 teaspoon (5 mL)
Recommended Use: As a dietary supplement, take one teaspoon (5 mL)
daily or as directed by your health care practitioner.
Product Contains:
- Calories 40:
- Calories from Fat 40:
- Total Fat 5 g:
- Cholesterol 32 mg:
- Omega 3 Fatty Acids 1355 mg:
- EPA (Eicosapentaenoic Acid) 725 mg:
- DHA (Docosahexaenoic Acid) 450 mg:
- Other Omega-3 Fatty Acids 180 mg:
Other Ingredients: Natural lemon flavor, natural tocopherols (vitamin
E).
This product does not contain: OmegAvail™ TG Liquid is fish oil in its 100%
natural TG (triglyceride) form. All DFH TruTG™ fish oil products are a minimum
90% natural TG bound omega 3 oils. OmegAvail™ Marine TG Liquid is processed
without solvents, and is completely free of chemicals such as hexane. Third
party testing also guarantees that it is free of pesticides, PCBs, dioxin, and
heavy metals including mercury.
Great care has been taken in selection of raw materials, and extensive
purification has taken place to make sure our OmegAvail™ Marine TG Liquid is
free of contamination by environmental pollutants. With the addition of natural
vitamin E as a antioxidant, and natural lemon flavor, the fishy aftertaste has
been significantly reduced and the stability of the product enhanced.
I highly recommend you take a look at the hundreds of research studies available proving the benefits of Omega 3s. Click HERE
Read Customer questions and answers about Fish Oils in our FAQ.
The TruTG™ Advantage
Fish oil is considered by many – if not the majority of nutritionally focused health care practitioners to be the single most important dietary supplement. In all probability, no other nutritional product has as much and varied research demonstrating its many health benefits.
Designs for Health has consistently embraced the Paleolithic nutritional philosophy upon which it was founded. As such, we are excited to announce our TruTG™ branded fish oil products which are guaranteed to contain 90 to 100% triglyceride-bound EPA and DHA fats. Both EPA and DHA are found naturally in fish in this triglyceride form.
The Form Nature Intended
Only Designs for Health fish oil products carry the TruTG™ seal – your assurance that our fish oils are delivered in the form found in nature, consistent with Paleolithic nutritional philosophy, and are of unmatched TG potency. Fish oil blends and concentrates bearing the TruTG™ seal are 90 to 100% triglyceride (TG) bound omega-3 fish oils, which are 40%-50% higher than industry standard for TG fish oil concentrate products!
Converting Ethyl Esters to Triglycerides - Why DFH Chose a Path Less Followed
The vast majority of fish oil concentrate products available on the market today are Ethyl Esters. Not surprisingly, the reason is cost; an additional step is required to convert EEs back into their natural TG state. This added process removes the ethanol backbone and re-esterifies the omega-3 fatty acids to a glycerol backbone. Interestingly, most of the companies that choose to take this extra step and expense convert just 60 – 65% of the oil to TG…leaving a mixture of EE, and mono and diglyceride oil in the remainder.
At Designs for Health, we have always placed quality, efficacy and safety above cost. This is precisely why we convert to TG the maximum amount possible, between 90% and 100%. TruTG™ defines this process, resulting in the highest expense, but also resulting in a finished product with the highest stability, bioavailability, and that closest to what is found in nature.
Superior Absorption and Biovailability
Numerous studies have assessed the absorption and bioavailability of EE fish oils by measuring the amount of EPA and DHA in blood plasma after ingestion of fatty acids as either TGs or EEs. Although a few studies have found the absorption rate to be similar between the two types of oils, overall evidence suggests that TG fish oils are better absorbed in comparison to EEs. One of the causative factors for the poor bioavailability of EE fish oil is a much greater resistance to digestive enzymes. During the digestive process, pancreatic lipase enzymes hydrolyze (cleave) the oils to liberate the fatty acids, and EE fish oil is much more resistant to this enzymatic process than the natural TG form.
A recent study assessed the specificity of 5 lipases towards EPA and DHA in TG and EE forms of fish oil. All of the investigated lipases hydrolyzed EPA and DHA more easily from a TG than from an EE fish oil substrate. It follows that EPA and DHA hydrolysis would be further compromised in individuals suffering from a digestive disorder, such as pancreatic insufficiency. EE fish oils should be avoided in such populations, as they would likely cause malabsorption of EPA and DHA.
A review of the existing literature provides evidence suggesting that omega-3 fatty acids in the natural TG form are more efficiently digested and significantly better incorporated into plasma lipids when compared to the EE form.
More Stable, Less Prone to Oxidation
Omega-3 fish oils in the form of EEs are much less stable than those in the natural TG form, making them more prone to oxidation. The oxidation kinetics of DHA as an EE or as a TG were assessed by measuring the concentration of oxygen found in the head space of a reaction vessel with both TG and EE forms3. The EE form of DHA was more reactive, and quickly oxidized, demonstrating that EE fish oils are far less stable and more readily produce harmful oxidation by-products3. In addition, the stability of DHA containing oil in phospholipid, triacylglycerol and the EE form has been assessed4. After a 10-week oxidation period, the EE DHA oil decayed 33% more rapidly than other forms4. In a separate study, monoglycerides were shown to be more readily oxidized when compared to triglycerides.
This suggests that individuals with health conditions associated with excessive oxidative stress should ideally consume only a 90+% TG form of fish oil.
Related Research
• Natural TG fish oil results in 50% more plasma EPA and DHA after absorption in comparison to EE oils6
• TG forms of EPA and DHA were shown to be 48% and 36%, respectively, better absorbed than EE forms7
• EPA incorporation into plasma lipids was found to be considerably smaller and took longer when administered as an EE8
• Plasma lipid concentrations of EPA and DHA were significantly higher with daily portions of salmon in comparison to 3 capsules of EE fish oil9
• In rats, DHA TG supplementation led to higher plasma and erythrocyte (red blood cell) DHA content than did DHA EE10 and a higher lymphatic recovery of EPA and DHA11.
References
1. Omega-3 fatty acids: the science and the beliefs. Ginsberg A, Stahl Z, Leventhal A. Harefuah. 2009 Feb;148(2):114-20, 138.
2. Lipolysis of menhaden oil triacylglycerols and the corre¬sponding fatty acid alkyl esters by pancreatic lipase in vitro: a reexamination. Yang LY, Kuksis A, Myher JJ. J Lipid Res. 1990 Jan;31(1):137- 47.
3. Autoxidation kinetic analysis of docosahexaenoic acid ethyl ester and docosahexaenoic triglyceride with oxygen sensor. Yoshii H, Furuta T, Siga H, Moriyama S, Baba T, Maruyama K, Misawa Y, Hata N, Linko P. Biosci Biotechnol Biochem. 2002 Apr;66(4):749-53.
4. Oxidative stability of docosahexaenoic acid-containing oils in the form of phospholipids, triacylglycerols, and ethyl esters. Song JH, Inoue Y, Miyazawa T. Biosci Biotechnol Biochem. 1997 Dec;61(12):2085-8.
5. Oxidation of monoglyceride, diglyceride, and triglyceride monolayers by aqueous potassium per manganate solution. Singh C. P. ; Shah D. O.
6. [Comparative bioavailability of eicosapentaenoic acid and docasahexaenoic acid from triglycerides, free fatty acids and ethyl esters in volunteers] Beckermann B, Beneke M, Seitz I. Arzneimittelforsc hung. 1990 Jun;40(6):700-4. German.
7. Human absorption of fish oil fatty acids as triacylglycerols, free acids, or ethyl esters. Lawson LD, Hughes BG. Biochem Biophys Res Commun. 1988 Apr 15;152(1):328-35.
8. Enteral absorption in man of eicosapentaenoic acid in different chemical forms. el Boustani S, Colette C, Monnier L, Descomps B, Crastes de Paulet A, Mendy F. Lipids. 1987 Oct;22(10):711-
9. Dietary intake of fish vs. formulations leads to higher plasma concentrations of n-3 fatty acids. Visioli F, Risé P, Barassi MC, Marangoni F, Galli C. Lipids. 2003 Apr;38(4):415-8.
10. Effect of supplementation with docosahexaenoic acid ethyl ester and sn-2 docosahexaenyl monoa cylglyceride on plasma and erythrocyte fatty acids in rats. Valenzuela A, Valenzuela V, Sanhueza J, Nieto S. Ann Nutr Metab. 2005 Jan-Feb;49(1):49-53. Epub 2005 Feb 25.
11. Digestion and lymphatic transport of eicosapentaenoic and docosahexaenoic acids given in the form of triacylglycerol, free acid and ethyl ester in rats. Ikeda I, Sasaki E, Yasunami H, Nomiyama S, Nakayama M, Sugano M, Imaizumi K, Yazawa K. Biochim Biophys Acta. 1995 Dec 7;1259(3):297-304.
|
|